C3 and kidney disorder: Within the subcohort of individuals with active renal disease, significantly more patients were anti-dsDNA antibody positive (p<0.001) and/or had pathologically low serum complement C3 and/or C4 levels (p<0.01) when compared with patients with inactive or no renal disease.